IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 20:00
IDEAYA Biosciences Shareholders Equity (Quarterly) : 1.199B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.199B |
| March 31, 2026 | 937.27M |
| December 31, 2025 | 1.023B |
| September 30, 2025 | 1.092B |
| June 30, 2025 | 959.65M |
| March 31, 2025 | 1.024B |
| December 31, 2024 | 1.059B |
| September 30, 2024 | 1.180B |
| June 30, 2024 | 931.66M |
| March 31, 2024 | 935.31M |
| December 31, 2023 | 621.09M |
| September 30, 2023 | 508.05M |
| June 30, 2023 | 501.61M |
| March 31, 2023 | 333.81M |
| December 31, 2022 | 349.46M |
| September 30, 2022 | 368.77M |
| Date | Value |
|---|---|
| June 30, 2022 | 269.32M |
| March 31, 2022 | 288.67M |
| December 31, 2021 | 301.51M |
| September 30, 2021 | 317.63M |
| June 30, 2021 | 240.26M |
| March 31, 2021 | 233.13M |
| December 31, 2020 | 198.27M |
| September 30, 2020 | 195.43M |
| June 30, 2020 | 172.06M |
| March 31, 2020 | 89.10M |
| December 31, 2019 | 100.40M |
| September 30, 2019 | 110.41M |
| June 30, 2019 | 120.61M |
| March 31, 2019 | 80.33M |
| December 31, 2018 | 89.44M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Xencor, Inc. | 503.23M |
| BioMarin Pharmaceutical, Inc. | 6.322B |
| MediciNova, Inc. | 37.27M |
| Viking Therapeutics, Inc. | 408.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.310B |
| Total Liabilities (Quarterly) | 110.79M |
| Debt to Equity Ratio | 0.0244 |
| Current Ratio | 10.45 |
| Net Debt Paydown Yield | -0.02% |